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1  | INTRODUCTION
Hypertrophic cardiomyopathy (HCM) is a common inherited disease 
of the heart muscle. The prevalence of the disease in the general 
population is approximately 1 in 500 (Maron et al., 2014). Some pa-
tients may remain asymptomatic throughout life but others may expe-
rience heart failure symptoms or sudden cardiac arrest. Symptomatic 
HCM is a now much more manageable condition with improved op-
tions for SCA prevention (e.g., subcutaneous implantable defibrillator) 
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Background: Fragmented QRS reflects disturbances in the myocardium predisposing 
the heart to ventricular tachyarrhythmias. Recent studies suggest that fragmented 
QRS (fQRS) is associated with worse major arrhythmic events in hypertrophic cardio-
myopathy (HCM). However, a systematic review and meta- analysis of the literature 
has not been done. We assessed the association between fQRS and major arrhythmic 




spective cohort studies that compared major arrhythmic events (sustained ventricular 
tachycardia, sudden cardiac arrest, or sudden cardiac death) in HCM with fQRS versus 
non-	fQRS.	Data	from	each	study	were	combined	using	the	random-	effects,	generic	
inverse	variance	method	of	DerSimonian	and	Laird	 to	calculate	 risk	 ratios	and	95%	
confidence intervals.
Results: Five studies from January 2013 to May 2017 were included in this meta- 
analysis involving 673 subjects with HCM (205 fQRS and 468 non- fQRS). Fragmented 
QRS	was	associated	with	major	arrhythmic	events	(pooled	risk	ratio	=	7.29,	95%	con-
fidence	interval:	4.00–13.29,	p < .01, I2	=	0%).
Conclusion: Baseline fQRS increased major arrhythmic events up to sevenfold. Our 
study suggests that fQRS could be an important tool for risk assessment in patients 
with HCM.
K E Y W O R D S
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2014).	Nonetheless,	 identification	of	patients	at	high	 risk	of	SCA	or	
sudden cardiac death remains challenging.
The	twelve-	lead	ECG	is	one	of	the	most	common,	useful	and	cost-	
effective investigations performed in clinical settings. Fragmented 
QRS (fQRS) is a marker of myocardial scar and identifies high- risk 
patients in various cardiac conditions, including acute coronary syn-
drome, cardiac sarcoidosis, Brugada syndrome, acquired long QT syn-
drome,	or	idiopathic	dilated	cardiomyopathy	(Das,	Khan,	Jacob,	Kumar,	
& Mahenthiran, 2006; Sha et al., 2011; Take & Morita, 2012). Recent 
studies suggest that fQRS is associated with increased major arrhyth-
mic	events	 in	patients	with	HCM	(Debonnaire	et	al.,	2015;	Femenia	
et	al.,	 2013;	Kang	et	al.,	 2014;	Nomura	et	al.,	 2015;	Ozyilmaz	et	al.,	
2017). However, no systematic review or meta- analysis of literature 
has been done to address the association in this group of patients. 
Therefore, we performed a systematicmeta- analysis to establish the 





to January 2017 using a search strategy that included the terms “frag-
mented QRS”, “QRS fragmentation” and “hypertrophic cardiomyopa-
thy”	(described	in	Data	S1).	Only	English	language	publications	were	
included. A manual search for additional pertinent studies and review 
articles using references from retrieved articles was also completed.
2.2 | Inclusion criteria
The eligibility criteria included the following:
1. Cohort studies (prospective or retrospective) reporting incidence 
of	major	arrhythmic	events	 (MAE)	 including	sustained	ventricular	
tachycardia, sudden cardiac arrest, or sudden cardiac death) in 
HCM patients with and without fQRS.
2. Relative	risk,	hazard	ratio,	odds	ratio,	incidence	ratio,	or	standard-
ized	incidence	ratio	with	95%	confidence	intervals	or	sufficient	raw	
data for these calculations had to be provided.
3. HCM participants without fQRS were used as controls.
Study eligibility was independently determined by two investiga-
tors	 (TR	and	NK)	and	differences	were	resolved	by	mutual	consensus.	
Newcastle–Ottawa	quality	assessment	scale	was	used	to	evaluate	each	
study in three domains: recruitment and selection of the participants, 
similarity and comparability between the groups, and ascertainment of 
the outcome of interest among cohort studies (Stang, 2010).
2.3 | Data extraction
A	standardized	data	collection	form	was	used	to	obtain	the	following	
information from each study: title of study, name of first author, year 
of study, year of publication, country of origin, number of participants, 
demographic data of participants, method used to identify cases and 
controls, method used to diagnose the outcomes of interest (fQRS 
and major arrhythmic events), and average duration of follow- up. 
Confounders were also assessed and adjusted effect estimates with 
95%	 confidence	 interval	 95%	 confidence	 intervals	 and	 covariates	
were included in the multivariable analysis.
To ensure accuracy, all investigators independently performed this 
data extraction process. Any data discrepancy was resolved by refer-
ring back to the original articles.
2.4 | Statistical analysis
We performed a meta- analysis of the included cohort studies using 
a random- effects model. The extracted studies were excluded from 
the analysis if they did not present an outcome in each intervention 
group or did not have enough information required for continuous 
data comparison. We pooled the point estimates from each study 
using	 the	 generic	 inverse-	variance	 method	 of	 DerSimonian	 and	
Laird	(1986).	The	heterogeneity	of	effect	size	estimates	across	these	
studies was quantified using the I2 statistic and Q statistic. For the 




sitivity analysis was performed to assess the influence of the indi-
vidual studies on the overall results by omitting one study at a time. 
Publication	bias	was	assessed	using	funnel	plot	and	Egger’s	regression	




3.1 | Description of included studies
Our search strategy yielded 15 potentially relevant articles (eight 
articles	from	EMBASE	and	seven	articles	from	MEDLINE).	After	ex-
clusion of three duplicate articles, 12 articles underwent title and ab-
stract review. One article was excluded because it was an abstract 
presentation. Six articles were excluded at this stage since they were 
not	cohort	studies,	did	not	report	the	outcome	of	 interest	 (MAE)	or	
were not conducted in patients with HCM, leaving five articles for full- 
length article review. Therefore, three retrospective and two prospec-
tive cohort studies of HCM patients (205 fQRS and 468 non- fQRS 
controls) were included in this meta- analysis. Figure 1 outlines the 
search and literature review process. The clinical characteristics and 
summary of included studies are described in Table 1.
3.2 | Quality assessment of included studies
Newcastle–Ottawa	 scales	 of	 the	 included	 studies	 are	 described	 in	
the	Table	S1.	The	Newcastle–Ottawa	scale	uses	a	star	system	(0–9)	
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to evaluate included studies on three domains: selection, compara-
bility, and outcomes. Higher scores represent higher study quality. 
Intra-	study	 risks	 of	 bias	 of	 included	 studies	 are	 also	 described	 in	
Table S2.
3.3 | Meta- analysis results
Five studies from January 2013 to May 2017 were included in this 
meta-	analysis.	All	of	five	studies	did	reveal	an	increased	MAE	among	
HCM patients with fQRS with four of the five studies achieving sta-
tistical significance. The pooled analysis demonstrated a statistically 
significant	 increased	 risk	of	MAE	 in	HCM	patients	with	 fQRS	 com-
pared	to	non-	fQRS	HCM	patients	with	 the	pooled	 risk	 ratio of	7.29	
(95%	confidence	 interval:	4.00–13.29,	p < .001, I2	=	0%).	There	was	
no statistical heterogeneity observed. Forest plot of our meta- analysis 
is shown in Figure 2.
3.4 | Sensitivity analysis
To assess the stability of the results of the meta- analysis, we con-
ducted a sensitivity analysis by excluding one study at a time. The 
results were not significantly altered indicating that our findings were 
robust.
3.5 | Publication bias
To investigate potential publication bias, we examined the contour- 
enhanced funnel plot of the included studies in assessing change in 




significant (p = .568) and confirmed no small study bias.
F IGURE  1 Search methodology and 
selection process
Potentially relevant articles identified from 
search of MEDLINE (n = 7) and EMBASE 
database (n = 8) and screened for retrieval
Title and abstract review of potentially 
relevant articles (n = 12)
1 article was excluded at this stage 
because of abstract presented 
Exclusion of 3 duplications
11 articles underwent full-length article 
review
6 articles were excluded at this stage 
as they were 
- 1 case report
- 2 no outcome of interest
- 1 conducted in non-hypertrophic 
cardiomyopathy
- 2 review article
5 articles underwent meta-analysis
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TABLE  1 The clinical characteristics and summary of included studies
Study
Debonnaire 
et al. (2015) Femenia et al. (2013) Kang et al. (2014) Nomura et al. (2015) Ozyilmaz et al. (2017)





Study design Prospective 
cohort
Retrospective cohort Retrospective cohort Retrospective cohort Prospective cohort
Year of 
publication
2015 2013 2014 2014 2017













between Feb 2001 
and Apr 2007
HCM patient followed at 
the	Kanazawa	
University Hospital and 
its affiliated hospitals 
from Sep 2008 to Mar 
2010
HCM patients aged 
more than 17 who 




Center, Training and 
Research Hospital and 
Bezmialem	Vakif	
University School of 
Medicine	between	Dec	









N/A Reduced LV function 
(LVEF	<50%),	QRS	
≤120	ms,	left	or	right	
bundle branch block, 
previous	ICD	
placement (n and age 
<18 years
Unable to obtain 
appropriate	ECG	data	at	
registration, clinical data 
missing, diagnosed with 
cardiac sarcoidosis after 
registration
Patients with previous 
history	of	aborted	SCD	
or those who had 
previously undergone 
ICD	implantation
Patients with history of 
septal ablation or 
myomectomy
Patients with hyperten-










52 ± 13 years)
102	patients	(52%	
male, mean age 
41.16 ± 18.25 years)
273	patients	(57%	




58 ± 17 years)
115	patients	(58%	male,	
mean age 
46.5 ± 15.3 years)
Number	of	
fQRS subjects




50 48 100 63 50
Median LV wall 
thickness (mm)




427 ± 28 430.38	±	22.98 438	±	29 436 ± 36 N/A




52 39 N/A N/A N/A
Unexplained 
syncope
17 60 15 N/A 13
Family	Hx	SCD 91 33 33 11 48
(Continues)
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4  | DISCUSSION
Hypertrophic cardiomyopathy is a complex inherited heart disease 
and	one	of	the	most	common	causes	of	sudden	cardiac	death	(SCD)	


























notching in the 
R or S wave or 
presence of >1 
additional R in 
≥2	beats	of	a	
non- aVR lead.
Presence of various 
RSR′	patterns,	which	
included an additional 
R′	or	notching	of	the	
R- wave, notching of 
the down- or upstroke 
of the S- wave, or the 
presence	of	>1R′	in	
two contiguous leads.
Presence of an 
additional	R′,	
notching in the nadir 
of the R or S wave, or 
the	presence	of	>1	R′	
in 2 contiguous leads 
that corresponded to 
a single myocardial 
territory.
QRS duration <120 ms Presence	of	R′	with	or	
without a Q wave on 
12-	lead	ECG,	the	
presence of notching 
on an R wave, the 
presence of notching 
on an S wave, or the 
presence of more than 
one	R′	wave	in	two	
adjacent derivations 
corresponding to the 
feeding area of one of 
the major coronary 
arteries
R′,	notching	in	nadir	of	
the S wave, notching of 
R	wave,	or	>1	R′	in	2	
contiguous leads
In patients with right or 
left bundle branch 
block (QRS duration 
≥120 ms)
RsR′	pattern	with	or	
without a Q wave, >2 
notches in the R wave, 
>2 notches in the 
downstroke or upstroke 
of the S wave, in two 
contiguous leads
Patients with mechanical 
pacing (QRS duration 
≥120 ms)
>2	R′	or	>2	notches	in	
the S waves in two 
contiguous leads








events (sustained VT 
and	SCD)
Major arrhythmic event 
(sudden cardiac death, 
sustained VT and VF)
Sudden cardiac death
Mean follow- up Median 5.7 years 
(IQR	2.7–9.1)




VT/VF and or 
SCD	in	HCM	
patients.
fQRS is associated with 
a significant increase 
in arrhythmic events 
in HCM patients with 
ICD	implant.
The presence of an 
fQRS, in particular in 
the inferior leads, 
wassignificantly 
associated with a 
higher risk of fetal 
ventricular arrhythmia 
events in HCM 
patients
fQRS is significantly 
associated with heart 
failure	with	hospitaliza-
tion and lower heart 
failure- free survival in 
HCM patient
fQRS significantly 
increase risk of 
ventricular arrhythmias 
and	SCD	in	HCM	
patients. fQRS is an 
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an essential part of clinical decision- making. Recommendations are 
based on cohort studies that identify relationships between clinical 
characteristics and prognostic outcomes.
Our	meta-	analysis	 summarized	 all	 available	 evidence	 of	MAE	 in	
HCM	from	five	studies,	a	total	of	779	patients.	Fragmented	QRS	was	
present	 in	 46%	 of	 the	 studied	 population.	 Our	 study	 revealed	 that	
HCM patients with fQRS have a statistically significant increased risk 
of	MAE	compared	to	those	without	fQRS	 (pooled	risk	ratio	of	7.29,	
95%	CI	4.00–13.29,	p < .001, I2	=	0%).	This	result	stresses	the	impor-
tance	of	 integrating	fQRS	 into	risk	stratification	of	HCM	for	SCD	 in	
clinical practice.
The importance of fQRS, which is suggestive of myocardial scar-
ring and fibrosis, has been increasingly supported by recent studies of 
MAE	in	various	cardiac	diseases	(Das	et	al.,	2006;	Konno	et	al.,	2015;	
Lu et al., 2017; Sha et al., 2011; Take & Morita, 2012), including HCM 
(Debonnaire	et	al.,	2015;	Konno	et	al.,	2015;	Lu	et	al.,	2017).	Fibrosis	
or tissue heterogeneity increases susceptibility to reentry and arrhyth-




depend on observed territory of distribution (Femenia et al., 2013; 
Kang	et	al.,	2014).	A	previous	study	of	HCM	patients	found	that	the	






ICDs	 may	 be	 considered	 in	 patients	 with	 HCM	 Risk-	SCD	 score	 of	
≥4%	to	6%	5-	year	risk	and	should	be	considered	if	5-	year	risk	≥6%.	
Variables	currently	used	in	HCM	Risk-	SCD	are	age,	family	history	of	
sudden cardiac death, unexplained syncope, left ventricular outflow 
gradient, maximum LV wall thickness, LA diameter, nonsustained 
ventricular tachycardia (Authors/Task Force Members, 2014). fQRS 





traditional markers significantly improved the specificity and positive 





which are observational in nature. Three out of five studies were 
retrospective. Secondly, our meta- analysis was only focused on 
MAE.	Given	 the	 published	 outcomes	 available	 for	 study,	we	 did	
not take overall mortality or total cardiovascular mortality into 
account. However, the recent study from Lu et al. (2017) shows 
that fQRS is associated with increased all- cause mortality, car-
diovascular	 disease	mortality,	 and	 heart	 failure	 related	 death.	 In	
addition, our data is not sufficient to determine the relationship 
between	fQRS	and	other	ECG	parameters	such	as	prolonged	QTc	
F IGURE  2 Forest plot of the included 
studies assessing the association between 
fragmented QRS and major arrhythmic 
events
Study, Year Risk ratio (95% CI)    %Weight
Overall  (I-squared = 0.0%, p = .525)
Nomura et al, 2014
Debonnaire et al, 2014














Favors non-fragmented QRS Favors fragmented QRS
Heterogeneity chi-squared = 3.20 (d.f. = 4)
Estimate of between-study variance Tau-squared = 0.00
Test for overall effect: z = 6.48 (p = .000)
F IGURE  3 Funnel plot of fragmented QRS and major arrhythmic 
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or territory of fQRS to the outcome of interest. According to 
Debonnaire	et	al.	(2015),	prolonged	QTc	is	an	independent	predic-
tor of ventricular arrhythmias and sudden cardiac death. Finally, 
there was some heterogeneity amongst the studies. However, we 
used sensitivity analysis methods in the random- effects model and 
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